Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haolang Technology is a China-based manufacturer specializing in intravascular and infusion therapy devices, including hemodialysis, central venous, peripheral venous, umbilical vessel, and peritoneal catheters, as well as infection control products. Its devices are registered with the FDA, manufactured in facilities certified to ISO 13485, and distributed globally, particularly in Asia, the Middle East, Latin America, Africa, and North America. The company emphasizes clinical outcomes, cost-effectiveness, and a strong R&D team with clinical and academic backgrounds[1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haolang Technology.